Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma

収録刊行物

  • Annals of Hematology

    Annals of Hematology 91 (2), 257-269, 2011-07-01

    Springer Science and Business Media LLC

被引用文献 (1)*注記

もっと見る

キーワード

問題の指摘

ページトップへ